Methodological and conceptual issues in functional magnetic resonance imaging: Applications to schizophrenia research

被引:16
作者
Brown, Gregory G. [1 ,2 ]
Eyler, Lisa T. [1 ,2 ]
机构
[1] Univ Calif San Diego, Psychol Serv, Vet Adm San Diego Hlthcare Syst, San Diego, CA 92161 USA
[2] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92161 USA
关键词
hypofrontality; hyperfrontality; BOLD;
D O I
10.1146/annurev.clinpsy.2.022305.095241
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Functional magnetic resonance imaging (MRI) is a noninvasive, highly repeatable, and increasingly available method to study disordered brain activity among patients with psychological or neurological disorders. In this chapter the biophysical principles underlying functional MRI are presented, and methodological limitations of the method are discussed. Artifacts related to the biophysical basis of the functional MRI signal or associated with image acquisition methods are presented, as are artifacts related to baseline effects-especially those associated with medication, caffeine, and nicotine use. The difficulties associated with the comparison of groups of subjects differing in performance receive special attention. The limitations of cognitive subtraction designs for functional MRI are also discussed. Functional MRI studies of schizophrenia patients are used to illustrate these points.
引用
收藏
页码:51 / 81
页数:33
相关论文
共 105 条
  • [51] Working memory capacity in schizophrenia: a parametric fMRI study
    Jansma, JM
    Ramsey, NF
    van der Wee, NJA
    Kahn, RS
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 68 (2-3) : 159 - 171
  • [52] More "mapping" in brain mapping: Statistical comparison of effects
    Jernigan, TL
    Gamst, AC
    Fennema-Notestine, C
    Ostergaard, AL
    [J]. HUMAN BRAIN MAPPING, 2003, 19 (02) : 90 - 95
  • [53] EFFECT OF LONG-TERM CAFFEINE TREATMENT ON A(1) AND A(2) ADENOSINE RECEPTOR-BINDING AND ON MESSENGER-RNA LEVELS IN RAT-BRAIN
    JOHANSSON, B
    AHLBERG, S
    VANDERPLOEG, I
    BRENE, S
    LINDEFORS, N
    PERSSON, H
    FREDHOLM, BB
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 347 (04) : 407 - 414
  • [54] The relationship between fMRI activation and cerebral atrophy: Comparison of normal aging and Alzheimer disease
    Johnson, SC
    Saykin, AJ
    Baxter, LC
    Flashman, LA
    Santulli, RB
    McAllister, TW
    Mamourian, AC
    [J]. NEUROIMAGE, 2000, 11 (03) : 179 - 187
  • [55] Spatial working memory among middle-aged and older patients with schizophrenia and volunteers using fMRI
    Kindermann, SS
    Brown, GG
    Zorrilla, LE
    Olsen, RK
    Jeste, DV
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 68 (2-3) : 203 - 216
  • [56] An fMRI study of semantic processing in men with schizophrenia
    Kubicki, M
    McCarley, RW
    Nestor, PG
    Huh, T
    Kikinis, R
    Shenton, ME
    Wible, CG
    [J]. NEUROIMAGE, 2003, 20 (04) : 1923 - 1933
  • [57] Nicotine use in schizophrenia: The self medication hypotheses
    Kumari, V
    Postma, P
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2005, 29 (06) : 1021 - +
  • [58] Cognitive effects of nicotine in humans: an fMRI study
    Kumari, V
    Gray, JA
    Ffytche, DH
    Mitterschiffthaler, MT
    Das, M
    Zachariah, E
    Vythelingum, GN
    Williams, SCR
    Simmons, A
    Sharma, T
    [J]. NEUROIMAGE, 2003, 19 (03) : 1002 - 1013
  • [59] Dietary caffeine consumption modulates fMRI measures
    Laurienti, PJ
    Field, AS
    Burdette, JH
    Maldjian, JA
    Yen, YF
    Moody, DM
    [J]. NEUROIMAGE, 2002, 17 (02) : 751 - 757
  • [60] Cognitive mechanisms of nicotine on visual attention
    Lawrence, NS
    Ross, TJ
    Stein, EA
    [J]. NEURON, 2002, 36 (03) : 539 - 548